KATHERINE WAUGH: Open Payments
NPI 1902266729 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 12 payments from 7 companies in 2025. Trend: 2023 $237 · 2024 $296 · 2025 $271
Food & beverage: $184Education: $87
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $118 |
| Axsome Therapeutics, Inc. | 3 | $77 |
| PFIZER INC. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 2 | $7 |
Products named: Auvelity, AUSTEDO XR, PAXLOVID, AIRSUPRA, REXULTI, COBENFY, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
